Acutus Medical Inc. (AFIB) Financial Statements (2024 and earlier)

Company Profile

Business Address 2210 FARADAY AVE
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:22,40338,47554,51669,57770,40066,302
Cash and cash equivalents19,17024,10023,05522,73825,58428,003
Short-term investments3,23314,37531,46146,83989,72638,299
Other undisclosed cash, cash equivalents, and short-term investments     (44,910) 
Restricted cash and investments 7,0307,0157,0027,1395,764150
Receivables11,3538,9527,6705,34021,0853,213
Inventory, net of allowances, customer advances and progress billings4,27815,72815,67114,93813,32714,596
Inventory4,27815,72815,67114,93813,32714,596
Disposal group, including discontinued operation510     
Other undisclosed current assets6782,4672,4444,7947,2919,633
Total current assets:46,25272,63787,303101,788117,86793,894
Noncurrent Assets
Operating lease, right-of-use asset3,1893,3593,5333,7083,8724,027
Property, plant and equipment8256,6117,2458,1459,22110,087
Intangible assets, net (including goodwill)  1,4331,4831,5331,5831,633
Intangible assets, net (excluding goodwill)  1,4331,4831,5331,5831,633
Restricted cash and investments      4,000
Disposal group, including discontinued operation, noncurrent assets3,600     
Other noncurrent assets94688731822897986
Total noncurrent assets:7,70812,09112,99214,20815,57320,733
TOTAL ASSETS:53,96084,728100,295115,996133,440114,627
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,64812,19215,25112,87114,40720,521
Taxes payable427
Employee-related liabilities6,539
Accounts payable2,7614,7545,4925,5694,7214,638
Accrued liabilities2,8877,4389,7597,3029,6868,917
Debt1,864     
Disposal group, including discontinued operation10,303     
Other undisclosed current liabilities1,1272,5752,9704,2395,465(2,199)
Total current liabilities:18,94214,76718,22117,11019,87218,322
Noncurrent Liabilities
Long-term debt and lease obligation32,65434,76134,63434,52634,43438,514
Long-term debt, excluding current maturities32,65434,76134,63434,52634,43434,310
Liabilities, other than long-term debt3,2433,4943,6993,8944,11510
Other liabilities  3220111210
Operating lease, liability3,2433,4623,6793,8834,1034,204
Total noncurrent liabilities:35,89738,25538,33338,42038,54938,524
Total liabilities:54,83953,02256,55455,53058,42156,846
Equity
Equity, attributable to parent(879)31,70643,74160,46675,01957,781
Common stock292929292928
Additional paid in capital599,935598,842597,578595,864594,173592,296
Accumulated other comprehensive loss(866)(953)(891)(798)(869)(1,121)
Accumulated deficit(599,977)(566,212)(552,975)(534,629)(518,314)(533,422)
Total equity:(879)31,70643,74160,46675,01957,781
TOTAL LIABILITIES AND EQUITY:53,96084,728100,295115,996133,440114,627

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues(7,532)5,2385,2894,1704,9623,644
Cost of revenue
(Cost of Goods and Services Sold)
13,146(8,595)(8,063)(6,790)(8,321)(6,951)
Gross profit:5,614(3,357)(2,774)(2,620)(3,359)(3,307)
Operating expenses30,072(9,579)(14,397)(14,687)11,862(24,105)
Other undisclosed operating income     8,3216,951
Operating income (loss):35,686(12,936)(17,171)(17,307)16,824(20,461)
Nonoperating income (expense)279(226)(1,175)992(1,634)36
Interest and debt expense(1,545)(1,409)(1,395)(1,307) (1,109)
Income (loss) from continuing operations before equity method investments, income taxes:34,420(14,571)(19,741)(17,622)15,190(21,534)
Other undisclosed income from continuing operations before income taxes1,5451,4091,3951,307 1,109
Income (loss) from continuing operations before income taxes:35,965(13,162)(18,346)(16,315)15,190(20,425)
Income tax expense (benefit) 12(75)    
Other undisclosed loss from continuing operations     (82) 
Income (loss) from continuing operations:35,977(13,237)(18,346)(16,315)15,108(20,425)
Loss before gain (loss) on sale of properties:(20,425)
Income from discontinued operations      
Other undisclosed net loss (69,742)     
Net income (loss) available to common stockholders, diluted:(33,765)(13,237)(18,346)(16,315)15,108(20,425)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income (loss):(33,765)(13,237)(18,346)(16,315)15,108(20,425)
Comprehensive income (loss):(33,765)(13,237)(18,346)(16,315)15,108(20,425)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 87(62)(93)71252(312)
Comprehensive income (loss), net of tax, attributable to parent:(33,678)(13,299)(18,439)(16,244)15,360(20,737)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: